Search

Life Sciences Regulatory Overview In this episode, we explore the complex regulatory landscape of the life sciences industry, providing attorneys with critical insights into the compliance requirements that govern pharmaceuticals, medical devices, and diagnostics. Whether you advise biotech startups...

Life Sciences Industry Basics This episode provides attorneys with a comprehensive foundation in the life sciences industry, equipping legal professionals with the knowledge needed to navigate this complex and highly regulated sector. Whether you advise pharmaceutical companies, biotech startups, or...

Saul Ewing's Intellectual Property attorneys hosted a half-day virtual conference that addressed the following trends and challenges affecting businesses and innovators nationwide: Learning how to combat brand impersonation and cyber fraud with legal tools, cybersecurity measures, and cross-industry...

Medical practices, dental practices and other health care entities must again comply with the federal Corporate Transparency Act (“CTA”). The deadline for compliance is March 21, 2025. What You Need to Know: The Corporate Transparency Act filing deadline is now March 21, 2025. Medical practices and...

Saul Ewing LLP's Consumer Financial Services Litigation Practice hosted their annual CLE program on Thursday, December 12. This program provided updates on consumer financial services civil litigation and government enforcement trends, including federal and state governments' top consumer protection...

Saul Ewing LLP's Consumer Financial Services Litigation Practice recently hosted their annual half-day CLE program on Thursday, December 14. This program provided updates on consumer financial services litigation and enforcement trends, including federal and state governments' top consumer...

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

Publication: American Bar Association ABA Business Law Section December 2018 The Business Law Section of the American Bar Association has published a 2018 supplement to The Law of Truth in Lending, a 1700-page treatise published in 2014, co-edited by Saul Ewing of Counsel John Ropiequet. The 900...

When allegations of research fraud or misconduct come to light, the stakes for companies and research institutions could not be higher. Actions such as fabrication of scientific data, manipulation of research materials, and plagiarism can result in damaged reputations, loss of federal funding, and...

Justin Beyer brings more than 20 years of experience to his work as a litigator focusing on disputes involving trade secrets and non-compete agreements. This includes representing companies who need to protect or reacquire misappropriated information or wish to hire a competitor's former employee...

Steven Reingold represents companies and their owners, executives, directors, and officers in complex disputes involving a wide variety of different industries. Drawing on decades of experience as a litigator in cases across the country, Steven handles claims involving contracts and loan documents...

Ian Mahany-Horton helps corporate clients protect their intellectual property through drafting and prosecuting patent applications and advising them on patent portfolio strategies for their innovations. Ian has experience working on patent matters for mechanical, electrical, and software...

Al Chakravarty helps to protect and defend organizations and individuals from issues that are enforced by federal and state agencies, including regulatory and compliance issues, whistleblower complaints, national security concerns, allegations of anti-competitive behavior, executive or employee...

A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...

Gianna Arnold helps companies protect, leverage and enforce their intellectual property and develop and memorialize strategic alliances in service to their goal of enhancing their value. Her understanding of the importance of these assets to the bottom line of a business stems in part from her past...

Eric Orlinsky concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity securities, mergers and acquisitions, purchases and sales of businesses. Eric also provides general...

Michael Denberg is a partner in the firm's Fort Lauderdale office. His practice focuses on real estate, structured financing, banking and condominium law representing developers, financial institutions and investors.

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...